Stem cells persist throughout life in diverse tissues by undergoing self-renewing divisions. Self-renewal capacity declines with age, partly because of increasing expression of the tumor suppressor p16 Ink4a . We discovered that the Hmga2 transcriptional regulator is highly expressed in fetal neural stem cells but that expression declines with age. This decrease is partly caused by the increasing expression of let-7b microRNA, which is known to target HMGA2. Hmga2-deficient mice show reduced stem cell numbers and self-renewal throughout the central and peripheral nervous systems of fetal and young-adult mice but not old-adult mice. Furthermore, p16 Ink4a and p19 Arf expression were increased in Hmga2-deficient fetal and young-adult stem cells, and deletion of p16
Ink4a and/or p19 Arf partially restored self-renewal capacity. let-7b overexpression reduced Hmga2 and increased p16
Ink4a /p19
Arf expression. Hmga2 thus promotes fetal and youngadult stem cell self-renewal by decreasing p16 Ink4a / p19
Arf expression. Changes in let-7 and Hmga2 expression during aging contribute to the decline in neural stem cell function.
INTRODUCTION
Stem cells self-renew throughout life in numerous tissues, including the central (CNS) and peripheral (PNS) nervous systems (Kruger et al., 2002; Maslov et al., 2004; Molofsky et al., 2006) . However, neural stem cell frequency, self-renewal capacity, and mitotic activity all decline with age along with the rate of neurogenesis (Enwere et al., 2004; Maslov et al., 2004; Molofsky et al., 2006) . Declines in stem cell function within aging tissues are partially caused by increasing p16
Ink4a expression. p16
Ink4a
generally cannot be detected in fetal and young-adult tissues but is induced in a variety of aging tissues Krishnamurthy et al., 2004; Molofsky et al., 2006) . p16 Ink4a deficiency partially rescues the decline in stem and progenitor cell function in the aging CNS and other tissues without affecting stem and progenitor cell function in young-adult tissues (Janzen et al., 2006; Krishnamurthy et al., 2006; Molofsky et al., 2006) . However, it remains uncertain what regulates this change in p16 Ink4a expression in old tissues and what mechanisms act in fetal and young-adult stem cells to increase their self-renewal relative to old-adult stem cells.
Consistent with the changes in stem cell function with age, different transcriptional programs regulate stem cell self-renewal at embryonic, fetal-neonatal, and adult stages. Fetal and neonatal hematopoietic stem cells (HSCs) depend on Sox17 for their maintenance, whereas adult HSCs do not, demonstrating the existence of a distinct fetal-neonatal self-renewal program (Kim et al., 2007) . Bmi-1-deficient mice are born with normal numbers of stem cells but exhibit postnatal self-renewal defects that lead to the depletion of adult stem cells (Lessard and Sauvageau, 2003; Molofsky et al., 2003; Park et al., 2003) . Other transcriptional regulators are also required by postnatal but not fetal stem cells (Hock et al., 2004a (Hock et al., , 2004b Shi et al., 2004) , demonstrating the existence of a postnatal-adult self-renewal program. This raises the question of whether all stage-specific transcriptional regulators of self-renewal cluster into temporally distinct embryonic, fetal-neonatal, and postnatal-adult programs.
Bmi-1 promotes the self-renewal of postnatal stem cells largely by repressing the expression of p16 Ink4a and p19 Arf (Bruggeman et al., 2005; Molofsky et al., 2005) . p16
Ink4a is a cyclindependent kinase inhibitor that promotes Rb activation, slowing cell-cycle progression or inducing cellular senescence (Lowe and Sherr, 2003) . p19 Arf promotes p53 activity, also slowing cell-cycle progression or inducing cellular senescence. Bmi-1 represses p16 Ink4a and p19 Arf expression within postnatal stem cells (Molofsky et al., 2003) . However, p16 Ink4a and p19 Arf expression increase in aging stem cells despite ongoing Bmi-1 expression (Molofsky et al., 2006) . In addition to contributing to the decline in stem cell function with age, p16 Ink4a , and perhaps p19 Arf , may also contribute to diseases of aging (Sharpless and DePinho, 2007 Hmga2 is a member of the high-mobility group A (HMGA) family that encodes a small, chromatin-associated protein that has no intrinsic transcriptional activity but can modulate transcription by altering chromatin structure (Reeves, 2001) . Hmga2 is widely expressed in undifferentiated cells during embryogenesis, but expression becomes more restricted as fetal development progresses (Zhou et al., 1995; Hirning-Folz et al., 1998) . Hmga2 is rarely detected within normal adult tissues but is expressed by a variety of benign and malignant tumors (Schoenmakers et al., 1995; Fusco and Fedele, 2007) . Recent studies have demonstrated that let-7 family microRNAs are important negative regulators of Hmga2 expression: loss of the let-7 binding sites in Hmga2 increases Hmga2 expression and promotes tumorigenesis (Lee and Dutta, 2007; Mayr et al., 2007; Yu et al., 2007) .
Hmga2
À/À mice exhibit a dwarf phenotype (Zhou et al., 1995) .
In contrast, overexpression of truncated (let-7-insensitive) HMGA2 in mice increases body size and the incidence of certain tumors (Arlotta et al., 2000; Fedele et al., 2006 
RESULTS

Hmga2 Expression Declines with Age in Stem Cells
We reasoned that genes that regulate changes in stem cell function with age might show progressive changes in their expression in stem cells with age. In a prior study, we identified 26 genes that were more highly expressed by fetal HSCs than by youngadult HSCs (Kiel et al., 2005) . In this study, we examined these genes by quantitative (real-time) PCR (qPCR) and with additional microarray data sets (data not shown) to identify genes that fit two additional criteria. First, we identified genes that remained detectably expressed by young-adult HSCs but declined significantly further in expression in old-adult HSCs (>3-fold, p < 0.01). Second, we identified genes that were more highly expressed in HSCs as compared to all CD45 + hematopoietic cells. Only one gene in a full-genome analysis met all of these criteria: Hmga2 ( Figures 1A and 1B) .
To test whether this unusual expression pattern is observed in other tissues, we examined Hmga2 expression in CNS stem and progenitor cells by performing qPCR on cells from embryonic day (E)14.5 telencephalon, postnatal day (P)0 lateral ventricle ventricular zone (VZ), P30 lateral ventricle subventricular zone (SVZ), P360 SVZ, and P720 SVZ (locations in which neural stem and progenitor cells reside within the forebrain). We again observed declining Hmga2 expression with age ( Figure 1C ). Hmga1 did not exhibit a similar change in expression with age by either microarray analysis in HSCs (data not shown) or by qPCR in CNS progenitors ( Figure 1C ). Hmga2 was also expressed at higher levels in CNS stem and progenitor cells as compared to differentiated cells by qPCR ( Figure 1D ), western blot ( Figure 1E ), and in situ hybridization ( Figure 1F ). We confirmed the decline in Hmga2 expression with age in neural stem and progenitor cells by both western blot ( Figure 1E ) and in situ hybridization ( Figure 1F ): Hmga2 expression was extinguished in the SVZ of old mice by every technique. The declining Hmga2 expression with age contrasted with the increasing expression of p16
Ink4a and p19 Arf with age in stem and progenitor cells ( Figure 1C ). These data raised the possibility that Hmga2 might contribute to the increased stem cell function in fetal and young-adult mice as compared to old-adult mice.
Hmga2 Promotes Fetal and Adult Neural Stem Cell Self-Renewal
To assess Hmga2 function, we examined Hmga2-deficient mice (Zhou et al., 1995) . Consistent with earlier reports (Benson and Chada, 1994; Zhou et al., 1995) , Hmga2 deficiency led to significant (p < 0.01) growth retardation that was evident by birth and that remained evident throughout adult life (Figures S1A-S1F available online). The brains of adult Hmga2 À/À mice were also significantly (p < 0.01) smaller than the brains of littermate controls (Figures S1G and S1H) . Despite this growth retardation, we detected no premature death among Hmga2 À/À mice.
To assess whether Hmga2 regulates changes in stem cell function during aging, we elected to focus on neural stem cells from the CNS and PNS because these stem cell populations exhibit clear declines in frequency, mitotic activity, and neurogenesis in vivo during aging (Kruger et al., 2002; Molofsky et al., 2006) . We cultured CNS stem cells from the forebrain of Hmga2 À/À mice and littermate controls to test whether Hmga2 was required for normal neural stem cell function ( Figure 2A ). Figures 2A and 2B ). These data suggest that Hmga2 is not required for the formation of stem cells during embryonic development but that Hmga2 À/À deficiency reduces self-renewal potential throughout fetal development and young adulthood, reducing stem cell frequency by birth and even further by adulthood.
To test whether Hmga2 is required for stem cell function in other tissues, we examined neural crest stem cells (NCSCs) from the guts of Hmga2 À/À mice and littermate controls. NCSCs give rise to the enteric nervous system within the gut during fetal development and then persist throughout adult life in the gut wall (Kruger et al., 2002) . In the PNS, the frequency of cells capable of forming multipotent neurospheres also did not differ between (D) Hmga2 and Hmga1 were elevated in SVZ versus differentiated layers of the cortex by qPCR in P30 wild-type mice (mean ± SD of three independent experiments; *p < 0.01,**p < 0.05).
(E) Western blot of E14.5 telencephalon, P0 VZ, and P600 SVZ. Consistent with results by qPCR (D) and in situ hybridization (F), Hmga2 protein levels (E) were elevated in undifferentiated cells within the VZ as compared to differentiated cells in the cortex but declined with age.
(F) In situ hybridization for Hmga2 on sections of E11.5, E14.5, P0, and P600 forebrains (* indicates lateral ventricle). Hmga2 transcript levels were greatly elevated in the VZ-SVZ but declined with age. All t tests were paired, except in (C).
Hmga2
À/À guts and littermate controls at E14.5 but was significantly reduced in Hmga2 À/À guts at P0 and P49-56 compared to littermate controls (p < 0.05; Figure S2B ). The Hmga2 À/À neurospheres were also significantly smaller (p < 0.01) and gave rise to fewer secondary multipotent neurospheres (p < 0.05) upon subcloning at all stages examined ( Figure S2B ). Hmga2 was thus required to maintain normal neural stem cell self-renewal and frequency throughout the PNS and CNS.
The reduced self-renewal of Hmga2-deficient CNS stem cells was associated with significantly reduced proliferation within stem cell colonies (p < 0.05; Figures 2C and 2F) but no detectable effect on cell death, whether this was assessed on the basis of activated caspase-3 staining ( Figure 2D ) or nuclear morphology ( Figure 2E ; cell death was rare in all colonies). In the PNS, Hmga2 deficiency also led to the formation of smaller colonies with a lower frequency of dividing cells ( Figures S2C-S2E ).
These data suggest that Hmga2 promotes neural stem cell selfrenewal by promoting division.
To assess whether the reduced self-renewal of Hmga2
neural stem cells could be rescued by Hmga2 overexpression, we infected P0 VZ cells from an Hmga2 À/À mouse with a dualpromoter lentivirus expressing Hmga2 and GFP, or control virus lacking Hmga2 (GFP-only). After infection, the cells were subcloned into secondary cultures to form neurospheres. GFP-only vector did not affect the diameter or self-renewal of neurospheres as compared to uninfected neurospheres within the same cultures ( Figure 2G ). In contrast, Hmga2 overexpression À/À mice and littermate controls that gave rise to multipotent neurospheres in culture, the diameter of these neurospheres, and their self-renewal potential (number and percentage of cells from individual primary neurospheres that gave rise to multipotent secondary neurospheres upon subcloning). Hmga2 deficiency significantly reduced self-renewal at all of these stages and stem cell frequency at P0 and P49-56 (mean ± SD for five to seven independent experiments per stage; *p < 0.01, **p < 0.05).
(C-E) P0 VZ cells were dissociated and plated in adherent cultures at clonal density (0.33 cells/ml) (C). Wild-type (+/+) stem cell colonies contained significantly more cells than did Hmga2
colonies (three independent experiments; error bars always represent the SD). The frequency of dying cells within multilineage colonies after 10 days in culture was examined on the basis of the basis of activated caspase-3 staining (D), or the frequency of condensed, fragmented nuclei identified by 4',6-diamino-2-phenylindole dihydrochloride (DAPI) staining (E significantly increased the diameter and self-renewal of neurospheres as compared to both uninfected neurospheres within the same cultures and GFP-only neurospheres (p < 0.05; Figure 2G ). Hmga2 overexpression can thus rescue the self-renewal defect in Hmga2 À/À neural stem cells.
To assess the effect of Hmga2 deficiency on neural stem cell differentiation, we adherently cultured cells from the P0 VZ at clonal density. We first examined multilineage colonies 7 days after plating. Hmga2 À/À colonies showed no signs of premature differentiation as only rare cells expressed neuronal or astrocytic markers in either Hmga2 À/À or wild-type colonies and no cells expressed the oligodendrocyte marker O4 ( Figure 3A ). We cultured cells for another 7 days in medium that promotes differentiation and observed similar multilineage differentiation to neurons, astrocytes, and oligodendrocytes in Hmga2 À/À and wild-type CNS stem cell colonies ( Figure 3B ). Similar results were observed in NCSC colonies (data not shown). Indeed, the vast majority of neurospheres cultured from the CNS and PNS at all stages of development underwent multilineage differentiation irrespective of Hmga2 genotype ( Figure S3 ). Hmga2 deficiency therefore does not affect the ability of neural stem cells to undergo multilineage differentiation. However, adherent stem cell colonies, like neurospheres, were significantly smaller in the absence of Hmga2 ( Figure 3A ).
Hmga2 Deficiency Leads to Defects in the CNS and PNS In Vivo
We examined proliferation in the SVZ of young-adult mice by administering a pulse of BrdU. Hmga2 À/À mice exhibited a significantly lower overall rate of proliferation in the SVZ in vivo , eight to ten sections counted per gut; *p < 0.01). All t tests were paired.
(p < 0.01; Figure 3C ). This was consistent with the reduced proliferation within Hmga2 À/À CNS stem cell colonies in culture ( Figure 2F ) and the reduced brain size of Hmga2 À/À mice (Figures S1G and S1H). The P0 VZ was also slightly but significantly thinner in Hmga2 À/À mice than in littermate controls ( Figure 3D ), consistent with the reduced stem cell frequency ( Figure 2B ) and overall mitotic activity ( Figure 3C ) in these mice. In the PNS, we counted the number of myenteric plexus neurons per transverse section through the distal ileum. Defects in NCSC self-renewal, such as those observed in the absence of Bmi-1, lead to a reduction in the number of neurons per section (Molofsky et al., 2003 (Molofsky et al., , 2005 . Young-adult Hmga2 À/À mice also had significantly fewer neurons per section than did littermate controls (p < 0.01; Figures  3E and 3F) . Hmga2 À/À mice exhibit phenotypes in vivo consistent with reduced proliferation by CNS and PNS neural stem cells.
Hmga2 Is Not Required for the Proliferation of Many Restricted Neural Progenitors
We examined the effect of Hmga2 deficiency on the proliferation of restricted neuronal progenitors (that make neuron-only colonies) and restricted glial progenitors (that make glia-only colonies) in adherent cultures at clonal density. Whether these restricted progenitors were cultured from the E14.5 telencephalon, the P0 VZ, or the P49-56 SVZ, the size and frequency of CNS neuron-only colonies and glia-only colonies were unaffected by Hmga2 deficiency (Figures 4A-4D ). The same was true in the PNS (Figures 4E-4H ). These results contrast with the reduced size of multilineage stem cell colonies from the CNS (Figure 2 ) and PNS ( Figure S2 ) in the absence of Hmga2 in both adherent and nonadherent cultures. Hmga2 therefore does not promote Figure 5A ) and PNS ( Figure 5B ) neurospheres from E14.5, P0, and P49-56 Hmga2 À/À mice as compared to littermate controls. Fetal neurospheres showed the greatest increase in p16 Ink4a and p19 Arf expression in the absence of Hmga2. Importantly, there was no effect of Hmga2 deficiency on p16
Ink4a or p19 Arf expression by neurospheres cultured from old (P570-600) mice, consistent with our failure to detect Hmga2 expression in neural stem and progenitor cells from old mice (Figure 1 ). The same trends were evident at the protein level by western blot in CNS ( Figure 5C ) and PNS ( Figure 5D ) neurospheres. p16 Ink4a and p19 Arf expression levels therefore increase in Hmga2 À/À CNS stem and progenitor cells from fetal and young-adult but not old-adult mice.
To ensure that Hmga2 also negatively regulates p16 Ink4a and p19 Arf expression in CNS stem and progenitor cells in vivo, we performed western blots on E14.5 telencephalon cells, P49-56 SVZ cells, and P570-600 SVZ cells from Hmga2 À/À mice and littermate controls. In wild-type mice, p16 Ink4a and p19 Arf were not detectable in cells from fetal telencephalon or young-adult SVZ but became detectable in old-adult SVZ ( Figure 5E ), consistent with a prior study (Molofsky et al., 2006) . In contrast, p16 Ink4a and p19
Arf were expressed in fetal telencephalon and youngadult SVZ of Hmga2 À/À mice, though the levels in old-adult SVZ were not affected by Hmga2 deficiency ( Figure 5E ). Hmga2 is thus required to repress p16 Ink4a and p19 Arf expression by CNS stem and progenitor cells from fetal and young-adult mice, but not old-adult mice, in vitro and in vivo.
Overexpression of Hmga2 in neurospheres cultured from the P0 VZ of Hmga2 À/À mice also rescued the p16 Ink4a expression phenotype (p19 Arf was not assessed in this experiment because of the limited protein available). Overexpression of Hmga2 in wild-type neurospheres only slightly increased Hmga2 protein levels and did not affect p16 Ink4a levels ( Figure 5F ); however, overexpression of Hmga2 in Hmga2 À/À neurospheres restored approximately normal Hmga2 and p16 Ink4a protein levels ( Figure 5F ).
These results were also confirmed with an shRNA against Hmga2, which partially knocked down Hmga2 protein expression within CNS neurospheres, increasing p16
Ink4a expression and reducing self-renewal potential ( Figure S4 ). Arf deficiency did not significantly affect the percentage of wild-type SVZ cells that gave rise to multipotent neurospheres in culture, the diameter of these neurospheres, or their self-renewal potential (number or percentage of cells from individual primary neurospheres that gave rise to multipotent secondary neurospheres upon subcloning; Figure 6A ). In contrast, p16
Ink4a /p19 Arf deficiency significantly (p < 0.05) but partially rescued the reductions in the percentage of Hmga2 À/À SVZ cells that gave rise to multipotent neurospheres in culture, the diameter of Hmga2 À/À neurospheres, and their self-renewal potential ( Figure 6A ). p16 Ink4a /p19 Arf deficiency also significantly but partially restored the frequency and self-renewal potential of Hmga2 À/À NCSCs ( Figure S5A ). Figure 6C ) did not affect the percentage of wild-type SVZ cells that gave rise to multipotent neurospheres in culture, the diameter of these neurospheres, or their self-renewal potential. In contrast, p16 Ink4a deficiency ( Figure 6B ) or p19 Arf deficiency ( Figure 6C) Figure 7A to Figure 2B and Figure S2B to Figure S7A ) as previously reported (Molofsky et al., 2006) . Hmga2 deficiency did not significantly affect the percentage of SVZ cells or outer muscle layer gut cells from old mice that formed multipotent neurospheres in culture, the diameter of these neurospheres, or their self-renewal potential ( Figure 7A ; Figure S7A ). Interestingly, the frequencies of CNS and PNS cells that could form stem cell colonies in culture recovered to near wild-type levels in old Hmga2 À/À mice, suggesting that homeostatic mechanisms are able to restore normal neural stem cell frequencies in old mice, when Hmga2 is no longer required for self-renewal. Hmga2 deficiency also did not significantly affect the number of cells per colony or the rate of BrdU incorporation within CNS ( Figures S7B and S7C ) or PNS ( Figures S7D and S7E ) stem cell colonies cultured from old mice. Finally, Hmga2 deficiency did not significantly affect the overall rate of proliferation within the SVZ of old mice ( Figure 7B ). These data demonstrate that Hmga2 is not required for the self-renewal of neural stem cells in old mice, in contrast to its role in fetal and young-adult mice.
Increasing let-7 Expression Contributes to the Decline in Hmga2 Expression with Age
We compared the expression of seven members of the let-7 family by qPCR in E14.5 telencephalon, P0 VZ, P360 SVZ, and P720 SVZ. Only let-7b showed progressive increases in expression with age that inversely correlated with the declines in Hmga2 expression ( Figure 7C ). To test whether elevated expression of let-7b in neural stem cells could reduce their self-renewal potential, we overexpressed let-7b and GFP in wild-type cells cultured from P0 VZ using a dual promoter lentivirus (Rubinson et al., 2003) . The GFP-only control virus did not significantly affect the diameter of neurospheres or the self-renewal of multipotent neurospheres as compared to uninfected neurospheres within the same cultures ( Figure 7D ). However, the let-7b+GFP virus did significantly (p < 0.01) reduce the diameter of neurospheres and the self-renewal of multipotent neurospheres compared to uninfected neurospheres within the same cultures, as well as compared to GFP-only infected neurospheres in sister cultures ( Figure 7D ). let-7b overexpression in these neurospheres also reduced Hmga2 expression and increased p16 Ink4a expression (p19 Arf was not assessed in these experiments because of the limited protein) ( Figure 7F , first panel). These data indicate that increasing let-7b expression can reduce Hmga2 expression, increase p16 Ink4a expression, and reduce self-renewal, potentially explaining the changes that are observed in aging neural stem cells. We also tested whether Hmga2 overexpression could increase the self-renewal of neural stem cells from old mice. Interestingly, overexpression of wild-type Hmga2 in neural stem cells did not significantly affect neurosphere diameter or the selfrenewal of multipotent neurospheres from old wild-type ( Figure 7E ) or Hmga2 À/À mice ( Figure S7F ). Moreover, in contrast to what was observed in neurospheres from the P0 VZ ( Figure 5F ), overexpression of wild-type Hmga2 in neurospheres from the P600 SVZ only marginally increased Hmga2 protein levels, irrespective of whether the cells were from wild-type or Hmga2 À/À mice ( Figure 7F ). Since we had observed significantly increased let-7b expression in P720 SVZ ( Figure 7C ), we hypothesized that Hmga2 expression in old neural stem cells is limited by increased let-7b expression. To test this, we overexpressed a form of Hmga2 with a wild-type coding sequence but a truncated 3 0 untranslated region that lacks the let-7 binding sites. This let-7-insensitive form of Hmga2 increased Hmga2 protein levels and reduced p16
Ink4a protein levels in neurospheres from old mice similar to those observed in neurospheres from newborn mice ( Figure 7F ). Overexpression of let-7-insensitive Hmga2 also significantly (p < 0.05) increased the diameter and self-renewal potential of multipotent neurospheres from P600 wild-type mice ( Figure 7E ) and Hmga2 À/À mice ( Figure S7F ).
These data suggest that increasing let-7 expression within aging neural stem and progenitor cells contributes to the decline in Hmga2 expression in these cells. Arf locus by chromatin immunoprecipitation ( Figure S8A ). In contrast, we have been able to detect Hmga2 binding to the JunB locus ( Figure S8A ). JunB promotes p16
Ink4a /p19 Arf expression in stem cells (Passegue et al., 2004) .
To test whether Hmga2 regulates JunB expression, we compared JunB transcript levels by qPCR in neurospheres cultured from E14.5 telencephalon, P0 VZ, P49-56 SVZ, and P600 SVZ from Hmga2 À/À mice and littermate controls. We observed significantly increased JunB expression in Hmga2 À/À neurospheres as compared to wild-type neurospheres cultured from the fetal and young-adult but not the old-adult stage in both the CNS ( Figure S8B ) and PNS ( Figure S8C ). Finally, JunB expression levels increased with age in wild-type SVZ cells ( Figure S8D ). These data are all consistent with the possibility that Hmga2 negatively regulates JunB expression by a mechanism that involves binding to the JunB locus and that JunB promotes p16 Ink4a /p19 Arf expression in the absence of Hmga2. Although
Hmga2 has generally appeared to be a transcriptional activator, there are some contexts in which it has appeared to have repressive activity (Reeves, 2001) . We consider this model for Hmga2 function preliminary because it will be necessary to generate and age Hmga2/JunB compound mutant mice to functionally evaluate the model.
DISCUSSION
Neural stem cell frequency, self-renewal potential, mitotic activity, and neurogenesis all decline with age (Kruger et al., 2002; Enwere et al., 2004; Maslov et al., 2004; Molofsky et al., 2006) . However, the mechanisms that increase the frequency and function of fetal and young-adult stem cells relative to old-adult stem cells have remained unclear. One important insight was the discovery that p16 Ink4a expression is induced in aging tissues Krishnamurthy et al., 2004) and that this contributes to the decline in stem and progenitor cell function with age (Janzen et al., 2006; Krishnamurthy et al., 2006; Molofsky et al., 2006) . p19
Arf expression also increases in aging tissues, though it has not yet been tested whether this contributes to the decline in stem cell function or tissue regenerative capacity with age. The recent discovery of polymorphisms near the p16 Ink4a /p19 Arf locus that are associated with age-related diseases suggests that this locus may be broadly involved in agerelated morbidity (Sharpless and DePinho, 2007 and references therein) . For these reasons, it is important to understand the mechanisms that regulate changes in p16 Ink4a /p19 Arf expression and stem cell function with age.
In this study, we demonstrate that Hmga2 increases the frequency and self-renewal of fetal and young-adult stem cells as compared to old-adult stem cells (Figure 2 and Figure S2B ), partly by negatively regulating the expression of p16
Ink4a and Our results are consistent with a number of prior studies that found Hmga2 to be a proto-oncogene (Fusco and Fedele, 2007) and raise the possibility that the tumorigenic effects of Hmga2 may partly reflect its ability to negatively regulate the expression of the p16
Ink4a and p19 Arf tumor suppressors. Another recent study found that HMGA1 and HMGA2 can promote cellular senescence by cooperating with p16
Ink4a to promote the formation of senescence-associated heterochromatin foci (SAHF) in cultured human fibroblasts (Narita et al., 2006) . Our results are not inconsistent with those of Narita et al. for two reasons. First, Narita et al. found that HMGA1 was necessary for the formation of SAHF but that HMGA2 had much less effect (Narita et al., 2006) . This raises the possibility that the main physiological function of Hmga2 may be to promote stem cell function in fetal and young-adult mice, whereas Hmga1 may be the main regulator of cellular senescence. (Bracken et al., 2007) . Together, our data suggest the existence of a novel pathway that regulates stem cell aging: let-7b expression increases with age in neural stem cells, decreasing Hmga2 expression, which in turn increases JunB and p16
Ink4a /p19 Arf expression, reducing stem cell frequency and function. Future studies will be required to further evaluate the roles of let-7 family members and JunB in this pathway, but the data in this study clearly demonstrate an important role for Hmga2 in regulating age-related changes in stem cell function and p16 Ink4a /p19 Arf expression.
EXPERIMENTAL PROCEDURES
Hmga2
+/À (Zhou et al., 1995) , p16 Ink4a /p19 Arf+/À (Serrano et al., 1996) , p16 Ink4a+/À (Sharpless et al., 2001) , and p19 Arf+/À (Kamijo et al., 1997) mice were housed at the University of Michigan Unit for Laboratory Animal Medicine and backcrossed at least six times onto C57BL/Ka background. All mice were genotyped by PCR as described in the Supplemental Data.
Cell Culture and Self-Renewal Assay CNS and PNS progenitors were isolated as described in prior studies (Molofsky et al., 2003 (Molofsky et al., , 2005 ) (see the Supplemental Data for details). For adherent cultures, CNS and PNS progenitors were plated at a clonal density of 0.33 cells/ml (500 cells per 35 mm well), in 6-well plates (Corning) that had been sequentially coated with 150 mg/ml poly-d-lysine (Biomedical Technologies, Stoughton, MA) and 20 mg/ml laminin (Sigma). For the nonadherent culture of neurospheres, CNS and PNS progenitors were plated at a density of 0.67-1.33 cells/ml (1000-2000 cells per 35 mm well) in ultra-low binding 6-well plates (Corning). The medium was a 5:3 mixture of Dulbecco's modified Eagle's medium (DMEM)-low:neurobasal medium, supplemented with 20 ng/ml recombinant human bFGF (R&D Systems, Minneapolis, MN), 1% N2 supplement (GIBCO), 2% B27 supplement (GIBCO), 50 mM 2-mercaptoethanol, and penicillin and streptomycin (Biowhittaker). ''Self-renewal medium'' for CNS cultures (designed to promote the expansion of undifferentiated cells) also contained 20 ng/ml epidermal growth factor (EGF) (R&D Systems) and 10% chick embryo extract (CEE). ''Self-renewal medium'' for PNS cultures contained 15% CEE, 35 mg/ml (110 nM) retinoic acid (Sigma), and 20 ng/ml IGF1 (R&D Systems). ''Differentiation medium'' for CNS cultures contained 10 ng/ml (instead of 20 ng/ml) bFGF, no EGF, no CEE, and 5% fetal bovine serum (GIBCO). Differentiation medium for PNS cultures was the same except that retinoic acid was also added. All cultures were maintained at 37 C in 6% CO 2 , balance air. For the measurement of self-renewal, individual primary CNS neurospheres were dissociated by trituration and then replated at clonal density in nonadherent secondary cultures. Individual PNS neurospheres were replated for 72 hr into adherent plates then treated with trypsin and collagenase (four parts 0.05% trypsin-ethylenediaminetetraacetic acid (EDTA) plus one part 10 mg/mL collagenase IV) for 3 min at 37 C followed by trituration. Secondary neurospheres were counted 7-9 days later and then transferred to adherent cultures containing differentiation medium for assessment of the percentage of secondary neurospheres that could undergo multilineage differentiation. For viral infection experiments, CNS progenitors were plated at a high density of 10 cells/ml and cultured adherently in CNS self-renewal medium. After 48 hr, viral supernatant was added for 24 hr and then switched to CNS selfrenewal medium for a further 24 hr. Cells were harvested by incubating for 1.5 min at 37 C in trypsin/EDTA and transferred to nonadherent cultures to form neurospheres for 6-7 days. See the Supplemental Data for details regarding retroviral vector construction and packaging.
Immunocytochemistry
Neurospheres were tested for multipotency by replating of one neurosphere per well of 48-well plates coated with poly-d-lysine and laminin (as described above) and then culturing adherently in differentiation medium for 5-10 days prior to immunohistochemical staining (see the Supplemental Data). For proliferation studies, cells were pulsed with 10mM BrdU (Sigma) for 20 min (CNS cells) or 60 min (PNS cells), fixed in 70% ethanol for 30 min at À20 C, and stained with anti-BrdU antibody (1:100, Caltag, Burlingame, CA). For caspase-3 staining, plates were fixed for 10 min at room temperature in 4% paraformaldehyde, blocked, and then stained with anti-activated caspase-3 antibody (1:1000, Pharmigen, San Diego, CA). In all cases, cells were counterstained for 10 min at room temperature with 10 mg/ml DAPI (Sigma D-8417).
Western Blots
Cells or tissues were resuspended in ice-cold cell lysis buffer (Cell Signaling Technology) with protease inhibitor cocktail (complete mini-tablet, Roche) and incubated for 15 to 30 min on ice. SDS-PAGE was done in 4%-20% Tris-Glycine Gels (Invitrogen) and transferred to platelet-derived growth factor (PVDF) membranes (Millipore). The membranes were blocked in Tris-buffered saline with 0.05% Tween-20 and 5% milk, incubated with primary and secondary antibodies, and washed according to standard procedures. Primary antibodies were rabbit polyclonal anti-Hmga2 (a generous gift from M. Narita and S. Lowe), rabbit polyclonal anti-p16 Ink4a (M-156; Santa Cruz Biotechnology), rabbit polyclonal anti-p19 ARF (ab80, Abcam), and mouse monoclonal anti-b-actin (sc-47778; Santa Cruz).
Quantitative RT-PCR For let7 family expression experiments, small RNAs (<200 nt) were extracted with the mirVana miRNA isolation kit (Ambion 
